Xortx Therapeutics inc (XRTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access XRTX quarterly Balance Sheets →
Balance sheet data covering Xortx Therapeutics inc– offers a view into how Dec 31 2025's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2021)
Assets
Cash And Cash Equivalents0.86
Cash & Short-term Investments0.00
Accounts receivable0.08
Other Current Assets0.32
Total Current Assets1.26
Equipment/Property/Plant Net0.00
Intangible AssetsAnd Goodwill0.19
Prepaid Expenses-
Current Prepaid Expenses0.02
Deferred Acquisition Costs Current0.29
Contract Payments Non Current-
Total Assets2.68
Liabilities
Other Liabilities, Current0.00
Total Current Liabilities0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.60
NoncurrentDerivativeFinancialLiabilities-
Total Liabilities0.60
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity0.00
Total Stockholder's Equity0.00
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Xortx Therapeutics inc balance sheet history.

About Xortx Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-032775

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License